Barclays Issues Positive Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price target upped by equities researchers at Barclays from $1,575.00 to $1,700.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s target price points to a potential upside of 10.54% from the company’s current price.

MTD has been the subject of a number of other research reports. Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, September 8th. Stifel Nicolaus raised their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. Rothschild & Co Redburn started coverage on shares of Mettler-Toledo International in a report on Wednesday, September 2nd. They issued a “sell” rating and a $1,200.00 target price for the company. Morgan Stanley upped their price target on shares of Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 4th. Finally, Royal Bank Of Canada began coverage on shares of Mettler-Toledo International in a research note on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 price target on the stock. Five research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $1,459.54.

Mettler-Toledo International Trading Up 0.3%

Shares of Mettler-Toledo International stock traded up $4.86 during trading hours on Wednesday, reaching $1,537.93. 42,816 shares of the company’s stock were exchanged, compared to its average volume of 180,294. Mettler-Toledo International has a 52-week low of $1,023.05 and a 52-week high of $1,585.72. The company has a fifty day moving average of $1,416.38 and a 200-day moving average of $1,295.27. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 159.45. The firm has a market capitalization of $30.82 billion, a price-to-earnings ratio of 34.56, a price-to-earnings-growth ratio of 3.09 and a beta of 1.19.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, beating the consensus estimate of $10.78 by $0.68. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The firm had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the firm posted $10.09 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Sell-side analysts forecast that Mettler-Toledo International will post 47.35 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the completion of the sale, the chief executive officer owned 4,480 shares in the company, valued at approximately $6,384,000. This trade represents a 17.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gerry Keller sold 240 shares of the firm’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total value of $342,513.60. Following the sale, the insider owned 259 shares in the company, valued at approximately $369,629.26. The trade was a 48.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,254 shares of company stock worth $6,092,712 over the last three months. 0.71% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MTD. BlackRock Inc. acquired a new stake in Mettler-Toledo International during the 2nd quarter valued at $2,404,713,000. T. Rowe Price Investment Management Inc. grew its stake in shares of Mettler-Toledo International by 0.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after acquiring an additional 3,157 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of Mettler-Toledo International during the second quarter worth about $762,553,000. Wellington Management Group LLP increased its position in shares of Mettler-Toledo International by 908.6% during the second quarter. Wellington Management Group LLP now owns 459,064 shares of the medical instruments supplier’s stock worth $586,459,000 after acquiring an additional 413,547 shares during the last quarter. Finally, Amundi lifted its stake in shares of Mettler-Toledo International by 40.7% in the second quarter. Amundi now owns 240,640 shares of the medical instruments supplier’s stock worth $307,420,000 after acquiring an additional 69,620 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer of precision instruments and related services used in laboratory, industrial, food processing, pharmaceutical and retail applications. The company’s solutions help customers measure, analyze, inspect and control materials and products throughout research, manufacturing and distribution processes.

Its product portfolio includes laboratory balances and scales, analytical instruments, automated chemistry systems, titrators, density and refractometry equipment, process analytics, industrial weighing systems, product inspection technologies and retail weighing and labeling solutions.